Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2022-01-17 108844
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2022-01-17 108841
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 40MG Updated Report 2022-01-17 107747
ESOMEPRAZOLE SIVEM PHARMACEUTICALS ULC Actual shortage 20MG Updated Report 2022-01-17 119343
DILANTIN-125 SUSPENSION UPJOHN CANADA ULC Actual shortage 125MG Updated Report 2022-01-17 151037
VIACORAM SERVIER CANADA INC Actual shortage 10MG 14MG New Report 2022-01-17 152922
OPTIMYXIN EURO-PHARM INTERNATIONAL CANADA INC Actual shortage 0.025MG 10000UNIT Updated Report 2022-01-17 124877
LIORESAL INTRATHECAL 2MG/ML NOVARTIS PHARMACEUTICALS CANADA INC Resolved 2MG Updated Report 2022-01-17 148460
LIORESAL INTRATHECAL 0.5MG/ML NOVARTIS PHARMACEUTICALS CANADA INC Resolved 0.5MG Updated Report 2022-01-17 148466
FOLIC ACID INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 5MG Updated Report 2022-01-17 152914

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
FLUOROURACIL INJECTION USP PFIZER CANADA ULC Discontinued 50MG Updated Report 2022-01-17 125282
ZYVOXAM 600 MG PFIZER CANADA ULC Discontinued 600MG Updated Report 2022-01-17 103480
PMS-CILAZAPRIL PHARMASCIENCE INC To be discontinued 1.0MG Updated Report 2022-01-17 110517
TRANSDERM-NITRO 0.6 NOVARTIS PHARMACEUTICALS CANADA INC Discontinued 0.6MG Updated Report 2022-01-17 138767
DEXTROSE INJECTION USP ICU MEDICAL CANADA INC Discontinued 100MG Updated Report 2022-01-17 141414
STERILE WATER FOR INJECTION USP ICU MEDICAL CANADA INC Discontinued 100% Updated Report 2022-01-14 152657
!!T3 PROPYL-THYRACIL PALADIN LABS INC. Discontinued 50MG Updated Report 2022-01-13 101076
!!T3 PROPYL-THYRACIL PALADIN LABS INC. Discontinued 100MG Updated Report 2022-01-13 107174
!!T3 ERWINASE JAZZ PHARMACEUTICALS FRANCE SAS Discontinued 10000UNIT Updated Report 2022-01-13 129623
STERILE WATER FOR INJECTION USP ICU MEDICAL CANADA INC To be discontinued 100% New Report 2022-01-12 152615
EXTAVIA NOVARTIS PHARMACEUTICALS CANADA INC To be discontinued 0.3MG New Report 2022-01-12 152532
TOBRAMYCIN INJECTION, USP MYLAN PHARMACEUTICALS ULC Discontinued 40MG New Report 2022-01-12 152485
STATEX SUPPOSITORIES 30MG PALADIN LABS INC. Discontinued 30MG Updated Report 2022-01-11 152444
TEVA-AMITRIPTYLINE TEVA CANADA LIMITED Discontinued 50MG New Report 2022-01-07 152378
TEVA-AMITRIPTYLINE TEVA CANADA LIMITED Discontinued 25MG New Report 2022-01-07 152375
TEVA-AMITRIPTYLINE TEVA CANADA LIMITED Discontinued 25MG New Report 2022-01-07 152351
BLES BLES BIOCHEMICALS INC Discontinued 500MCG 27MG Updated Report 2022-01-04 143216
ULORIC TAKEDA CANADA INC Discontinued 80MG Updated Report 2022-01-04 144266
ATRIPLA GILEAD SCIENCES, LLC Discontinued 300MG 200MG 600MG Updated Report 2022-01-01 144260
PNEUMOVAX 23 MERCK CANADA INC Discontinued 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG 25MCG Updated Report 2021-12-18 151479